6515--Treatment Modality for Management of Ocular Surface and Eyelid Disease

In accordance with FAR 10, Market Research, responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to the Sources Sought Notice. The purpose of this announcement is to gain market research knowledge of potential qualified sources and their size classification.

The Department of Veterans Affairs Coatesville VA Medical Center, 1400 Blackhorse Hill Rd, Coatesville, PA 19320, is seeking potential sources capable of providing a new

System for Management of Ocular Surface and Eyelid Disease capable of treating dry eye syndrome, meibomian gland disease, blepharitis, Acne Rosacea, and conditions affecting the skin around the eyes in accordance with the Draft Statement of Need (SON) below.

The Government s purpose of this Sources Sought is to determine if there are manufacturer systems capable of meeting all the salient characteristics listed in the SON.

Please include the following information in your response:

Company name

Address

Contact person name, phone number, and email address

UEI #

Business size/classification/type (i.e. 8a, Hubzone, SDVOSB, VOSB, etc.)

FSS/eCAT/SAC/NAC/NASA SEWP or any other Government held contract, if applicable provide the number.

NAICS: 334510

Size Standard: 1250 Employees

Provide brochures, pamphlets, hyperlinks, or any other materials necessary to determine material capabilities including special features and any express or implied warranties.

Please answer the following questions:

Provide the brand name, country of origin, and all manufacturer part # s for the listed system.

Are you the manufacturer, distributor, or equivalent solution to the above items? If not, can you provide additional information, as shown below? This confirms compliance with the nonmanufacturer rule IAW 13 CFR 121.406(b) Nonmanufacturers.

If you are a large business, do you have any designated distributors? If so, please provide their company name, telephone, Point of Contact, and size status (if available).

If you re a small business, are you an authorized distributor/reseller for the items identified above? If so, please include your letter of authorization on the OEM s letterhead.

If you re a small business and you are an authorized distributor/reseller for the items identified above or an equivalent solution, do you alter, assemble, or modify the items requested in any way? If you do, state how and what is changed, assembled, or modified.

Responses to this Sources Sought Notice shall be submitted directly via email to jefferson.mann@va.gov. Responses that only include generic marketing material and do not provide for capability to meet requirements listed in the SON may not be considered. Responses must be received no later than 6:00 am ET, 07/27/2026. No solicitation document is available at this time. This notice is simply for Market Research Purposes Only. All information received in response to this RFI that is marked as proprietary will be handled accordingly. The VA will not reimburse any potential contractors for any costs associated with this Sources Sought Notice.

STATEMENT OF NEED (SON)

Coatesville Veterans Affairs Medical Center (VAMC)

Optometry Department

Treatment Modality for Management of Ocular Surface and Eyelid Disease

DESCRIPTION:

The Optometry Department of Coatesville VA Medical Center (VAMC) requires a device specifically designed to address ocular surface and eyelid diseases, such as dry eye syndrome, meibomian gland disease, blepharitis, Acne Rosacea, and related skin conditions around the eyes. The required technology must utilize dual frequency monopolar Radio Frequency (RF) and electronic dynamic muscle stimulation (DMS) to deliver heat and muscle stimulation at varying tissue depths. This modality aims to increase blood circulation, enhance meibomian gland function, improve muscle tone, and boost blinking efficiency, thereby providing relief for patients with these conditions.

The device must employ monopolar RF technology, which is essential as it reduces the risk of electrical arcing and ensures rapid, uniform heating of deeper eyelid tissues.

Dual frequency RF technology is necessary because it does not cause skin depigmentation and is not contraindicated for any patient population. This feature allows for more aggressive management of dry eye in all veterans at Coatesville. Treatments with this technology enhance blood circulation, stimulate collagen production, and support meibomian gland function. Treatments enhance blood circulation, stimulate collagen production, and provide meibomian gland function.

Dynamic muscle stimulation is also required for mechanical, non-invasive correction of eyelid muscle tone to restore normal function. Abnormal eyelid function increases the risk of corneal surface irregularities, epithelial breakdown, and permanent vision loss. Dynamic muscle stimulation uses controlled electrical pulses to reactivate and restore resting muscle tone in the orbicularis oculi. These treatments improve blinking efficiency, stabilize the natural tear film, protect the cornea from progressive exposure damage, and reduce the need for daily home care.

SCOPE:

The contractor shall provide a new FDA approved Monopolar Dual Frequency RF with Electronic Dynamic Muscle Stimulation. The device must be able to treat patients of all skin tones for dry eye syndrome, meibomian gland disease, blepharitis, Acne Rosacea, and conditions affecting the skin around the eyes. All minimum salient characteristics must be met.

The Lumenis BE OptiLift System is a Name Brand Product provided for reference of salient characteristics only.

SALIENT CHARACTERISTICS

FDA-approved specifically for ophthalmic and optometric use

Clinically validated for treatment of all scope diagnoses

Monopolar Application

Utilizes dual frequency technology

Utilizes electronic dynamic muscle stimulation

Multiple RF frequencies capable of tailoring depth and intensity of treatments to specific skin thickness and patient needs

Non-pigment dependent system

No required anesthesia, topical numbing creams, injections, or eye drops

Zero post-procedure downtime

Touch screen display

Rounded electrode contoured for eyes to maximize patient safety and comfort

Automatic treatment presets

DELIVERY REQUIREMENTS:

Supplier shall perform all required assembly in accordance with the manufacturers instructions.

Supplier shall inspect to ensure that the system is clean, has no scratches and that the installation is complete and ready for patient use. The vender will provide on-site training to staff.

Vendor shall remove all trash, cartons, debris, and must provide and execute a recycling plan for cartons and cardboard disposal.

Vendor shall be responsible for delivery, assembly/installation, and training during normal business hours Monday-Friday 7:30 am to 4:30 pm, excluding any declared Federal Holidays.

Scheduling for delivery shall be coordinated at least 7 business days prior to shipment.